← All organizations
Highest phase reached
Phase 4
First clinical trial
May 20, 2015Last known activity
Oct 31, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 7 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (10)
- NCT06585020CollaboratorPhase 2Oct 31, 2024
- NCT06547866OfficialPhase 2Oct 1, 2024
- NCT04359511Overall official - principal investigatorPhase 3May 31, 2020
- NCT04000334Overall official - principal investigatorN/ASep 30, 2019
- NCT04000334Lead sponsorN/ASep 30, 2019
- NCT03587610Lead sponsorN/AMay 24, 2018
- NCT03587610Overall official - principal investigatorN/AMay 24, 2018
- NCT03071601Lead sponsorPhase 4Apr 1, 2017
- NCT03071601Overall official - principal investigatorPhase 4Apr 1, 2017
- NCT02595970Overall official - principal investigatorPhase 3May 20, 2015
Details
- Last known activity
- Oct 31, 2024